Login / Signup

Histidine-Triad Hydrolases Provide Resistance to Peptide-Nucleotide Antibiotics.

Eldar YagmurovDarya TsibulskayaAlexey LivenskyiMarina SerebryakovaYuri I WolfSergei BorukhovKonstantin SeverinovSvetlana Dubiley
Published in: mBio (2020)
The Escherichia coli microcin C (McC) and related compounds are potent Trojan horse peptide-nucleotide antibiotics. The peptide part facilitates transport into sensitive cells. Inside the cell, the peptide part is degraded by nonspecific peptidases releasing an aspartamide-adenylate containing a phosphoramide bond. This nonhydrolyzable compound inhibits aspartyl-tRNA synthetase. In addition to the efficient export of McC outside the producing cells, special mechanisms have evolved to avoid self-toxicity caused by the degradation of the peptide part inside the producers. Here, we report that histidine-triad (HIT) hydrolases encoded in biosynthetic clusters of some McC homologs or by standalone genes confer resistance to McC-like compounds by hydrolyzing the phosphoramide bond in toxic aspartamide-adenosine, rendering them inactive.IMPORTANCE Uncovering the mechanisms of resistance is a required step for countering the looming antibiotic resistance crisis. In this communication, we show how universally conserved histidine-triad hydrolases provide resistance to microcin C, a potent inhibitor of bacterial protein synthesis.
Keyphrases
  • induced apoptosis
  • cell cycle arrest
  • public health
  • oxidative stress
  • genome wide
  • staphylococcus aureus
  • mesenchymal stem cells
  • cell therapy
  • multidrug resistant
  • dna methylation
  • klebsiella pneumoniae